期刊文献+

肝纤维化无创诊断的相关研究进展 被引量:5

下载PDF
导出
摘要 肝纤维化是指肝脏发生各种慢性疾病时所经历的共同的病理过程。目前研究已经表明,肝纤维化并非不可逆转的疾病。经过适当的治疗后,肝纤维化程度可得到减轻或是逆转。因此,确定肝纤维化的程度,对于了解疾病进展、拟定适当的治疗方案、判定疗效、了解疾病的自然史具有着重要的临床意义。
作者 罗爽 邢卉春
出处 《中国肝脏病杂志(电子版)》 CAS 2014年第3期87-90,共4页 Chinese Journal of Liver Diseases:Electronic Version
基金 首都医学科学发展基金(2007-3054) 国家自然科学基金(81201160) 国家科技重大专项课题(2014ZX10005001)
  • 相关文献

参考文献2

二级参考文献78

  • 1[1]Yoshida H,Shiratori Y,Moriyama M,Arakawa Y,Ide T,Sata M,Inoue O,Yano M,Tanaka M,Fujiyama S,Nishiguchi S,Kuroki T,Imazeki F,Yokosuka O,Kinoyama S,Yamada G,Omata M.Interferon therapy reduces the risk for hepatocellular carcinoma:national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.IHIT Study Group.Inhibition of Hepatocarcinogenesis by Interferon Therapy.Ann Intern Med 1999; 131:174-181
  • 2[2]Poynard T,McHutchison J,Davis GL,Esteban-Mur R,Goodman Z,Bedossa P,Albrecht J.Impact of interferon alfa2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.Hepatology 2000; 32:1131-1137
  • 3[3]Bravo AA,Sheth SG,Chopra S.Liver biopsy.N Engl J Med 2001; 344:495-500
  • 4[4]Cadranel JF,Rufat P,Degos F.Practices of liver biopsy in France:results of a prospective nationwide survey.For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).Hepatology 2000; 32:477-481
  • 5[5]Poynard T,Ratziu V,Bedossa P.Appropriateness of liver biopsy.Can J Gastroenterol 2000; 14:543-548
  • 6[6]Maharaj B,Maharaj RJ,Leary WP,Cooppan RM,Naran AD,Pirie D,Pudffin DJ.Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.Lancet 1986; 1:523-525
  • 7[7]Bedossa P,Dargere D,Paradis V.Sampling variability of liver fibrosis in chronic hepatitis C.Hepatology 2003; 38:1449-1457
  • 8[8]The French METAVIR Cooperative Study Group.Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C.The French METAVIR Cooperative Study Group.Hepatology 1994; 20:15-20
  • 9[9]Engstrom-Laurent A,Loof L,Nyberg A,Schroder T.Increased serum levels of hyaluronate in liver disease.Hepatology 1985; 5:638-642
  • 10[10]Niemela O,Risteli L,Sotaniemi EA,Risteli J.Type Ⅳ collagen and laminin-related antigens in human serum in alcoholic liver disease.Eur J Clin Invest 1985; 15:132-137

共引文献35

同被引文献69

  • 1Sun-Jae Lee,Kyung-Hyun Kim,Kwan-Kyu Park.Mechanisms of fibrogenesis in liver cirrhosis:The molecular aspects of epithelial-mesenchymal transition[J].World Journal of Hepatology,2014,6(4):207-216. 被引量:18
  • 2张文胜,王宝恩,贾继东,欧晓娟,王泰龄,钱林学,张福奎,马红,尤红.超声综合评估系统诊断慢性乙型肝炎肝纤维化[J].中华肝脏病杂志,2007,15(4):249-253. 被引量:29
  • 3Friedman SL. Mechanisms of hepatic fibrogenesis [ J ]. Gastroen- tero1,2008,134(6) :1655 - 1669.
  • 4Friedman SL. Hepatic stellate cells : protean, muhifunctional, and enigmatic cells of the liver [ J ]. Physiol Rev, 2008,88 ( 1 ) : 125 - 172.
  • 5Ellis EL,Mann DA. Clinical evidence for the regression of liver fibrosis[J]. J Hepatol,2012,56(5) :1171 - 1180.
  • 6Tang A, Kim TK, Heathcote J, et al. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis [ J ]. Ultrasound Med Biol, 2011,37 (12) :1963 - 1969.
  • 7Faria SC, Ganesan K, Mwangi I,et al. MR imaging of liver fi- brosis : current state of the art [ J ]. Radiographics,2009,29 (6) : 1615 - 1635.
  • 8Castera L. Noninvasive methods to assess liver disease in pa- tients with hepatitis B or C [ J]. Gastroenterol, 2012,142 (6) : 1293 - 1302.
  • 9Sandrin L,Fourquet B. Hasquenoph JM, et al. Transient elasto- graphy: a new noninvasive method for assessment of hepatic fi- brosis [ J ]. Ultrasound Med Biol, 2003,29 ( 12 ) : 1705 - 1713.
  • 10Jung MK, Cho H J, Lee HC, et al. Comparison of transient elas- tography and hepatic fibrosis assessed by histology in chronic liver disease [ J 3. Korean J Gastroenterol, 2008, 51 ( 4 ) : 241 - 247.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部